Health Condition 1: 4- Measurement and Monitoring
Conditions
Interventions
Intervention1: Levosulpride: Levosulpride will be started 25 mg QID if the gastric residual volume is above threshold of 150ml and if gastric feed intolerance, is further evaluated as an episodes of v
Sponsors
RAHUL SHARMA
Eligibility
Inclusion criteria
Inclusion criteria: 1) Critically ill enterally fed patients. 2) Anticipated ICU stay of atleast 5 days. 3) Not on any prokinetics for feed intolerance. 4) Patients giving consent for participating in the study.
Exclusion criteria
Exclusion criteria: 1) Bowel surgery within 24 hours. 2) Gastrointestinal bleed, obstruction, perforation, malabsorption syndrome. 3) Abnormal Liver function tests; SGOT/ SGPT more than three times normal and/ or total bilirubin more than three times normal. 4) Hemodynamic instability (MAP less than 70). 5) Morbid obesity/ pregnancy (unable to achieve right lateral position).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find specificity and sensitivity of Ultrasonographic assessment and manual aspiration technique for measurement of GRV. Timepoint: All the enterally fed patients fulfilling the inclusion criteria would be subjected to bedside ultrasonography for measurement of gastric reserve volume followed by manual aspiration for the same measurement twice a day at morning and evening prior to feed with last feed atleast 4 hours prior to estimation of GRV. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of gastric feed intolerance in our ICU. Assessment of other features of gastric intolerance eg. vomiting, flatulence, diarrhea and stomach ache in the study group. Role of Levosulpiride in preventing gastric intolerance. Side effects of the drug if used.Timepoint: 12 months | — |
Countries
India
Contacts
Public ContactRahul Sharma
IGMC SHIMLA , Himachal Pradesh 171001
Outcome results
None listed